#delta4
❤️𝐖𝐨𝐫𝐥𝐝 𝐇𝐞𝐚𝐫𝐭 𝐃𝐚𝐲

For a long time, cardiovascular disease, kidney disease, obesity and diabetes have been approached as separate problems. The emerging concept of 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫–𝐤𝐢𝐝𝐧𝐞𝐲–𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 (𝐂𝐊𝐌) 𝐡𝐞𝐚𝐥𝐭𝐡 brings these systems together.

For us at #Delta4, this systems-level perspective matters.
September 29, 2026 at 8:26 AM
Last year, we swapped laptops for lawn chairs.

This year, we needed more lawn chairs than ever. 😄

There were more of us to fill them at our biggest Delta4 BBQ yet!

Good food, good company, and a well-earned afternoon away from our screens. ☀️🌭

#Delta4 #TeamDelta4 #SummerBBQ
September 7, 2026 at 11:29 AM
What is it like to work with Delta4?

Across nephrology, oncology, neuroimmunology & beyond, our partners highlight scientific rigor, computational expertise and our ability to turn complex biomedical data into actionable insights.

See what others say: delta4.ai/services/

#DrugDiscovery
August 18, 2026 at 7:16 AM
Delta4’s AI drug discovery engine is available directly on a global life science marketplace, making it easier for pharma and biotech teams to explore new indications and drug repositioning opportunities with Hyper‑C.

🔗 Discover more in a blog by Scientist.com: www.scientist.com/blog/acceler...
August 10, 2026 at 10:20 AM
Finding the right #compounds for the right #diseases is a key challenge in #DrugRepositioning. Delta4’s Hyper-C platform starts with disease biology to identify promising therapeutic opportunities and provides mechanistic rationales to support development decisions.
Read more: delta4.ai/services/
August 4, 2026 at 11:35 AM
Ballistic Missile Submarines. putinazi sea leg amputation. Northern & Pacific fleet. Borei & Borei A-class(project 955/955A)replacing Delta4 Definitely class. Payload:16 RSM-56 Bulava sub launched Ballistic missiles/slbms.older Delta4 carry liquid fueled R-29rmu Sineva/Lainer missiles.8300km(bulava)
July 31, 2026 at 11:00 PM
Many diseases require more than a single #therapeutic approach. With the support of #Combo-C, we identify and evaluate promising #DrugCombinations, providing the biological rationale behind each prediction—helping pharma prioritize candidates before the lab.
Explore: delta4.ai/services/
#Delta4
July 29, 2026 at 11:28 AM
Feed: "131 Off-Road"
By: Justin Nguyen on Monday, July 20, 2026
Delta4x4 Racing rebrands to Delta Gelandesport
delta4×4’s racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com
July 21, 2026 at 4:29 AM
delta4×4's racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.

131offroad.com/2026/07/20/d...

#Dakar2027 #DakarClassic
Delta4x4 Racing rebrands to Delta Gelandesport
delta4×4’s racing division, which competes in the Dakar Classic, has rebranded from delta4×4 Racing to DELTA Geländesport.
131offroad.com
July 20, 2026 at 9:31 PM
#SyntheticLethality is not only about new targets — it’s about treating the right patients in the right way.
With Hyper-C, Delta4 connects multi-omics data to prioritize synthetic lethal interactions and enable smarter patient selection and trial design. Read more:
🔗 delta4.ai/synthetic-lethality
July 16, 2026 at 11:20 AM
Diseases are rarely driven by a single pathway. Drugs rarely act on a single mechanism.
By integrating diverse biological data into a unified framework, the Hyper-C platform helps identify connections that may otherwise remain hidden.

Explore: delta4.ai/hyper-c/

#DrugDiscovery #AI #SystemsBiology
June 22, 2026 at 3:33 PM
#Synthetic lethality is a promising concept in precision oncology, but discovery remains the bottleneck. With ~20,000 genes, the number of possible interactions is enormous. Most remain unmapped, but computational approaches can help narrow the space. ➡️https://delta4.ai/synthetic-lethality
#Oncology
June 16, 2026 at 10:20 AM
The FDA is encouraging drug repurposing—finding new uses for existing drugs in areas of unmet need. At Delta4, we extend this to drug combinations, aiming to identify synergistic, multi-target strategies for complex diseases.
#DrugRepurposing #SystemsBiology #PrecisionMedicine
May 22, 2026 at 12:05 PM
#Delta4's Enrico presented his poster at the #YSA Symposium 2026 at the Medical University of Vienna. His work on systems-biological modeling of the #AKI-to-#CKD transition was selected for Session V (Regeneration & Transplantation) and sparked lively scientific discussion.
#TranslationalResearch
May 18, 2026 at 9:30 AM
Diseases like #ADPKD and #FSGS are driven by complex, interconnected biological networks.

What if the key to better therapies lies not in one target — but in understanding the system?

At Delta4, we advocate for a shift towards network-based approaches in #drugDiscovery.

#systemsbiology #techbio
April 28, 2026 at 7:34 AM
Delta4 will be represented at #Bio€quity Europe in Prague by Josef Thalmann, who will be on-site for investor meetings and collaboration discussions in the field of data-driven drug repositioning and indication expansion. If you plan to attend, feel free to reach out and schedule a conversation!
April 21, 2026 at 12:46 PM
WORLD #LIVER DAY: Liver safety and liver disease aren’t separate problems.
Cases like #Ontozry show risks still emerge post-approval, while PBC/PSC reflect immune-driven damage.
Different triggers—same system under stress.

Read more on #Delta4's work in #PBC/#PSC: delta4.ai/development-...
April 19, 2026 at 7:00 AM
In proof-of-concept clinical trials, mechanism matters more than magnitude. Targeted #biomarkers and multi-#omics approaches help researchers to:
🧬Confirm #target engagement, 🧬Identify #responder subgroups, 🧬Reduce noise in small #cohorts.
Read more:
delta4.ai/proof-of-con...
April 17, 2026 at 10:20 AM
Took a little break. Concentrated on what I could control.
April 16, 2026 at 10:13 PM
At Delta4, our commitment to the rare disease community is grounded in both compassion and rigorous data science. Together, we are transforming awareness into meaningful action—supporting innovation and hope for everyone affected by rare diseases. 💙💪

#Delta4 #RareDisease #Innovation
April 9, 2026 at 10:20 AM
💡 Most drug discovery tools look at biology in segments. Hyper-C is built to see diseases and drugs play out across systems. Explore Hyper-C's core components at 📍 delta4.ai/hyper-c
#DrugDiscovery #SystemsBiology #Biotech #TargetDiscovery #BiomarkerID #indicationExpansion
April 2, 2026 at 7:04 PM
#PerMediK’s 8th Meeting marked the start of its final year. A strong network driving collaboration in personalised medicine for #CKD — now facing the key task of aligning scientific exchange with real-world impact. Great to have Paul & Kinga from Delta4 on site, exchanging ideas and experience.
March 30, 2026 at 9:43 AM
Kidney disease highlights both the promise and the challenge of PoC clinical trials.
Slow disease progression and heterogeneous biology make traditional endpoints impractical in early studies.
🧬Explore more: delta4.ai/proof-of-con...
March 17, 2026 at 9:15 AM
Feed: "131 Off-Road"
By: Justin Nguyen on Wednesday, March 11, 2026
X-raid, delta4x4 release cross-country MAN TGE kit
For January’s Dakar Rally and Classic, X-raid Team and delta4×4 built a special kit for use on their MAN TGE service vans. The setup is now available for the public.
131offroad.com
March 12, 2026 at 7:24 AM
For January's Dakar Rally and Classic, X-raid Team and delta4×4 built a special kit for use on their MAN TGE service vans. The setup is now available for the public.

131offroad.com/2026/03/11/x...

#Dakar2026 #DakarRally #DakarClassic #MAN #MANTGE
X-raid, delta4x4 release cross-country MAN TGE kit
For January’s Dakar Rally and Classic, X-raid Team and delta4×4 built a special kit for use on their MAN TGE service vans. The setup is now available for the public.
131offroad.com
March 11, 2026 at 8:23 PM